This hypothesis is supported by the fact that in 57% of LCC cases, a mutation has been identified in the BRAF gene, which results in the replacement of glutamate with valine in the 600 codon—BRAF V600E [7]. This evidence concerns the gene BRAF and leukoencephalopathy with calcifications and cysts.